| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $62.5M | +45.4% |
| SG&A Expense | $17.4M | +9.5% |
| Operating Income | -$79.9M | -35.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$69.1M | -25.0% |
| EPS (Basic) | -$1.62 | -22.7% |
| EPS (Diluted) | -$1.62 | -22.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.0M | -76.9% |
| Current Assets | $211.7M | -17.7% |
| Total Assets | $225.9M | -15.1% |
| Current Liabilities | $15.3M | +169.0% |
| Total Liabilities | $21.6M | +158.6% |
| Stockholders' Equity | $204.3M | -20.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.1M | +0.3% |
| Capital Expenditures | $770K | +37.7% |
| Investing Cash Flow | -$144.6M | — |
| Financing Cash Flow | $1.5M | +143.2% |
| Free Cash Flow | -$50.9M | -0.1% |